Stanley P L Leong

Summary

Affiliation: California Pacific Medical Center Research Institute
Country: USA

Publications

  1. doi request reprint Biomarkers of cancer metastasis through the lymphovascular system: future perspectives
    Stanley P L Leong
    Center for Melanoma Research and Treatment, Department of Surgery, California Pacific Medical Center and Sutter Pacific Medical Foundation, California Pacific Medical Center Research Institute, 2340 Clay Street, 2nd Floor, San Francisco, CA 94115, USA
    Clin Exp Metastasis 29:861-4. 2012
  2. doi request reprint Progression of cutaneous melanoma: implications for treatment
    Stanley P L Leong
    Center for Melanoma Research and Treatment and Department of Surgery, California Pacific Medical Center, San Francisco, CA, USA
    Clin Exp Metastasis 29:775-96. 2012
  3. doi request reprint Impact of nodal status and tumor burden in sentinel lymph nodes on the clinical outcomes of cancer patients
    Stanley P L Leong
    Center for Melanoma Research and Treatment, Department of Surgery, California Pacific Medical and Research Institute, San Francisco, California 94115, USA
    J Surg Oncol 103:518-30. 2011
  4. pmc Is breast cancer the same disease in Asian and Western countries?
    Stanley P L Leong
    Department of Surgery, California Pacific Medical Center and Sutter Pacific Medical Foundation, 2340 Clay Street, 2nd Floor, San Francisco, CA 94115, USA
    World J Surg 34:2308-24. 2010
  5. doi request reprint Role of selective sentinel lymph node dissection in head and neck melanoma
    Stanley P L Leong
    Center for Melanoma Research and Treatment and Department of Surgery, California Pacific Medical Center and Research Institute, San Francisco, California, USA
    J Surg Oncol 104:361-8. 2011
  6. doi request reprint The Pivotal Role of the Lymphovascular System in Cancer Metastasis: future perspectives
    Stanley P L Leong
    Center for Melanoma Research and Treatment and Department of Surgery, California Pacific Medical Center and Research Institute, San Francisco, California 94115, USA
    J Surg Oncol 103:639-41. 2011
  7. pmc A phase 2 study of (99m)Tc-tilmanocept in the detection of sentinel lymph nodes in melanoma and breast cancer
    Stanley P L Leong
    California Pacific Medical Center and Sutter Pacific Medical Foundation and Research Institute, University of California, San Francisco, CA, USA
    Ann Surg Oncol 18:961-9. 2011
  8. doi request reprint Unique patterns of metastases in common and rare types of malignancy
    Stanley P L Leong
    Center for Melanoma Research and Treatmnet and Department of Surgery, California Pacific Medical Center and Research Institute, San Francisco, California 94115, USA
    J Surg Oncol 103:607-14. 2011
  9. doi request reprint Cutaneous melanoma: a model to study cancer metastasis
    Stanley P L Leong
    Center for Melanoma Research and Treatment and Department of Surgery, California Pacific Medical Center and Research Institute, San Francisco, California 94115, USA
    J Surg Oncol 103:538-49. 2011
  10. ncbi request reprint Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer
    Yah Yuen Tan
    Department of Surgery, UCSF Medical Center at Mount Zion, San Francisco, California, USA
    Breast J 11:338-43. 2005

Detail Information

Publications55

  1. doi request reprint Biomarkers of cancer metastasis through the lymphovascular system: future perspectives
    Stanley P L Leong
    Center for Melanoma Research and Treatment, Department of Surgery, California Pacific Medical Center and Sutter Pacific Medical Foundation, California Pacific Medical Center Research Institute, 2340 Clay Street, 2nd Floor, San Francisco, CA 94115, USA
    Clin Exp Metastasis 29:861-4. 2012
    ..With further understanding of the molecular mechanisms of metastasis, more targets are available for selective therapeutic intervention so that effective therapy can be delivered against cancer in a more personalized approach...
  2. doi request reprint Progression of cutaneous melanoma: implications for treatment
    Stanley P L Leong
    Center for Melanoma Research and Treatment and Department of Surgery, California Pacific Medical Center, San Francisco, CA, USA
    Clin Exp Metastasis 29:775-96. 2012
    ..With recent developments in molecular biology and genomics, novel molecular targeted therapy is being developed through clinical trials...
  3. doi request reprint Impact of nodal status and tumor burden in sentinel lymph nodes on the clinical outcomes of cancer patients
    Stanley P L Leong
    Center for Melanoma Research and Treatment, Department of Surgery, California Pacific Medical and Research Institute, San Francisco, California 94115, USA
    J Surg Oncol 103:518-30. 2011
    ....
  4. pmc Is breast cancer the same disease in Asian and Western countries?
    Stanley P L Leong
    Department of Surgery, California Pacific Medical Center and Sutter Pacific Medical Foundation, 2340 Clay Street, 2nd Floor, San Francisco, CA 94115, USA
    World J Surg 34:2308-24. 2010
    ..Future prospective data collection from Asian and Western countries may provide further interesting epidemiologic and outcome data regarding the outcome of women with breast cancer from Asian and Western countries...
  5. doi request reprint Role of selective sentinel lymph node dissection in head and neck melanoma
    Stanley P L Leong
    Center for Melanoma Research and Treatment and Department of Surgery, California Pacific Medical Center and Research Institute, San Francisco, California, USA
    J Surg Oncol 104:361-8. 2011
    ..Completion lymph node dissection is only indicated when the SLN is positive. A nerve stimulator should be used during selective SLND in the parotid and posterior triangle to minimize the injury to the facial and spinal accessory nerve...
  6. doi request reprint The Pivotal Role of the Lymphovascular System in Cancer Metastasis: future perspectives
    Stanley P L Leong
    Center for Melanoma Research and Treatment and Department of Surgery, California Pacific Medical Center and Research Institute, San Francisco, California 94115, USA
    J Surg Oncol 103:639-41. 2011
    ..In general, sentinel lymph node is the gateway to regional nodal metastasis and beyond. Biomarkers and gene profiles are being developed to stage and subgroup cancer patients more accurately for more effective personalized therapy...
  7. pmc A phase 2 study of (99m)Tc-tilmanocept in the detection of sentinel lymph nodes in melanoma and breast cancer
    Stanley P L Leong
    California Pacific Medical Center and Sutter Pacific Medical Foundation and Research Institute, University of California, San Francisco, CA, USA
    Ann Surg Oncol 18:961-9. 2011
    ..This novel molecular species provides the basis for potentially enhanced SLN mapping reliability...
  8. doi request reprint Unique patterns of metastases in common and rare types of malignancy
    Stanley P L Leong
    Center for Melanoma Research and Treatmnet and Department of Surgery, California Pacific Medical Center and Research Institute, San Francisco, California 94115, USA
    J Surg Oncol 103:607-14. 2011
    ..Perhaps, different subsets of cancer may be better defined with relevant biomarkers so that mechanisms of metastasis can be more accurately defined on a molecular and genomic level...
  9. doi request reprint Cutaneous melanoma: a model to study cancer metastasis
    Stanley P L Leong
    Center for Melanoma Research and Treatment and Department of Surgery, California Pacific Medical Center and Research Institute, San Francisco, California 94115, USA
    J Surg Oncol 103:538-49. 2011
    ..A future challenge is to develop a molecular taxonomy to subgroup melanoma patients at various stages of tumor progression for more accurate targeted treatment...
  10. ncbi request reprint Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer
    Yah Yuen Tan
    Department of Surgery, UCSF Medical Center at Mount Zion, San Francisco, California, USA
    Breast J 11:338-43. 2005
    ..These patients can be identified preoperatively based on imaging and biopsy criteria, allowing the option of selective intraoperative pathologic evaluation of the sentinel node and immediate completion axillary dissection as necessary...
  11. pmc A multimarker prognostic assay for primary cutaneous melanoma
    Mohammed Kashani-Sabet
    Auerback Melanoma Research Laboratory and Melanoma Center, Comprehensive Cancer Center, and Departments of Pathology, Surgery, and Urology, University of California San Francisco, San Francisco, California, USA
    Clin Cancer Res 15:6987-92. 2009
    ..To determine the prognostic significance of a multimarker assay incorporating expression levels of three molecular markers in primary cutaneous melanoma...
  12. ncbi request reprint The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer
    Yang Guo Fan
    Department of Surgery, University of California San Francisco Medical Center at Mount Zion, San Francisco, 94143 1674, USA
    Ann Surg Oncol 12:705-11. 2005
    ..We also report our experience with disease relapse in the era of SSL and attempt to correlate this with SLN tumor burden...
  13. doi request reprint Novel role for RGS1 in melanoma progression
    Javier Rangel
    Auerback Melanoma Research Laboratory, Cutaneous Oncology Program, UCSF Comprehensive Cancer Center, Department of Dermatology, University of California San Francisco, San Francisco, CA 94115, USA
    Am J Surg Pathol 32:1207-12. 2008
    ..0039). These results validate the role of RGS1 as a novel prognostic marker for melanoma given its impact on the survival associated with melanoma...
  14. ncbi request reprint Osteopontin as a molecular prognostic marker for melanoma
    Javier Rangel
    Auerback Melanoma Research Laboratory, Cutaneous Oncology Program, University of California San Francisco Comprehensive Cancer Center, San Francisco, California 94115, USA
    Cancer 112:144-50. 2008
    ..Osteopontin has been suggested as a marker of disease progression in patients with melanoma because of its overexpression in recent microarray analyses. However, its prognostic role in melanoma has not been fully defined...
  15. doi request reprint The effect of delay time between primary melanoma biopsy and sentinel lymph node dissection on sentinel node status, recurrence, and survival
    Brian M Parrett
    The Buncke Clinic, Plastic Surgery, California Pacific Medical Center, San Francisco, CA 94115, USA
    Melanoma Res 22:386-91. 2012
    ..53) between the less than 40 days and the at least 40 days groups. A modest delay in sentinel node dissection from the initial melanoma biopsy does not adversely affect sentinel node status, recurrence, nor survival...
  16. ncbi request reprint Long-term prognosis and significance of the sentinel lymph node in head and neck melanoma
    Brian M Parrett
    The Buncke Clinic, Division of Plastic Surgery, California Pacific Medical Center, San Francisco, California 94115, USA
    Otolaryngol Head Neck Surg 147:699-706. 2012
    ..To report the long-term significance of sentinel lymph node (SLN) biopsy on prognosis, determine false-negative SLN occurrences, and determine risk factors for death and recurrence in a large series of patients with head and neck melanoma...
  17. doi request reprint In-transit intramammary sentinel lymph nodes from malignant melanoma of the trunk
    Victoria Lyo
    Department of Surgery, California Pacific Medical Center, University of California San Francisco, San Francisco, CA, USA
    Ann Surg 255:122-7. 2012
    ..We hypothesize that regional metastasis to the breast from anterior trunk MM also occurs via the lymphatic system to these intramammary in-transit sentinel lymph nodes...
  18. ncbi request reprint Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study
    Sandra L Wong
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
    Ann Surg Oncol 13:809-16. 2006
    ..This multi-institutional study was undertaken to characterize patterns of failure and survival rates in these patients and to compare results with those of positive-SLN patients who underwent CLND...
  19. ncbi request reprint Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma
    Javier Rangel
    Auerback Melanoma Research Laboratory, Cutaneous Oncology Program, University of California San Francisco Comprehensive Cancer Center, San Francisco, CA 94115, USA
    J Clin Oncol 24:4565-9. 2006
    ..To assess the prognostic significance of nuclear receptor coactivator-3 (NCOA3) overexpression in primary cutaneous melanoma...
  20. ncbi request reprint Heterogeneous patterns of lymphatic drainage to sentinel lymph nodes by primary melanoma from different anatomic sites
    Stanley P L Leong
    Department of Surgery, UCSF Comprehensive Cancer Center at Mount Zion, San Francisco, California 94143 1674, USA
    Clin Nucl Med 30:150-8. 2005
    ..Preoperative lymphoscintigraphy was used to identify and classify SLN drainage basins and patterns of drainage...
  21. ncbi request reprint Clinical significance of occult metastatic melanoma in sentinel lymph nodes and other high-risk factors based on long-term follow-up
    Stanley P L Leong
    Department of Surgery, University of California, San Francisco, Medical Center at Mount Zion and CSF Comprehensive Cancer Center, 1600 Divisadero Street, Box 1674, San Francisco, California 94143, USA
    World J Surg 29:683-91. 2005
    ..CI 1.20,2.98), and age (HR= 1.26 95% CI 1.08, 1.47). SLN status was the most significant factor for melanoma recurrence and death. Other important predictors include tumor thickness, ulceration, lymphatic invasion, and mitotic index...
  22. doi request reprint The impact of primary melanoma thickness and microscopic tumor burden in sentinel lymph nodes on melanoma patient survival
    Frederick L Baehner
    Department of Pathology, University of California, San Francisco and UCSF Comprehensive Cancer Center, San Francisco, CA, USA
    Ann Surg Oncol 19:1034-42. 2012
    ....
  23. ncbi request reprint Prognostic significance of extent of ulceration in primary cutaneous melanoma
    Hege Grande Sarpa
    Melanoma Center, Cutaneous Oncology Program, Cancer Center, University of California, San Francisco, CA 94115, USA
    Am J Surg Pathol 30:1396-400. 2006
    ..These results suggest that no more than minimal ulceration is required to have a prognostic impact on melanoma survival...
  24. doi request reprint Selective sentinel lymph node dissection for melanoma: importance of harvesting nodes with lower radioactive counts without the need for blue dye
    Liang Chih Liu
    Department of Surgery, University of California, San Francisco, CA, USA
    Ann Surg Oncol 18:2919-24. 2011
    ....
  25. ncbi request reprint Internal mammary sentinel lymph node mapping for invasive breast cancer: implications for staging and treatment
    Catherine Park
    Department of Radiation Oncology, University of California, Mount Zion Medical Center, the UCSF Comprehensive Cancer Center, San Francisco, California, USA
    Breast J 11:29-33. 2005
    ..These factors may aid in the selection of patients who might benefit from further staging or treatment of the IMNs...
  26. ncbi request reprint Impact of multiple lymphatic channel drainage to a single nodal basin on outcomes in melanoma
    James K Wall
    Department of Surgery, UCSF, San Francisco, CA 94115, USA
    Arch Surg 142:753-7; discussion 756-8. 2007
    ..To determine the impact of multiple lymphatic channels (MLCs) on outcome in melanoma...
  27. ncbi request reprint Clinical patterns of metastasis
    Stanley P L Leong
    Department of Surgery, University of California, and UCSF Comprehensive Cancer Center, San Francisco, CA, USA
    Cancer Metastasis Rev 25:221-32. 2006
    ..Beyond the clinical patterns of metastasis, it is imperative to understand the biology of metastasis and to characterize patterns of metastasis perhaps due to heterogeneous clones based on their molecular signatures...
  28. ncbi request reprint Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients
    Stanley P L Leong
    Department of Surgery, University of California, San Francisco, CA 94115, USA
    Arch Otolaryngol Head Neck Surg 132:370-3. 2006
    ..To determine the impact of sentinel lymph node (SLN) status and other risk factors on recurrence and overall survival in head and neck melanoma patients...
  29. ncbi request reprint Patterns of metastasis in human solid cancers
    Stanley P L Leong
    Department of Surgery, University of California San Francisco, California, USA
    Cancer Treat Res 135:209-21. 2007
  30. ncbi request reprint Selective sentinel lymphadenectomy for breast cancer in the United States
    Stanley P L Leong
    Sentinel Lymph Node Program, Department of Surgery, University of California, San Francisco, CA 94143, USA
    Asian J Surg 27:268-74. 2004
    ..SSL is rapidly evolving into a standard approach for staging primary breast cancer in the United States, without the maturation of results from clinical trials...
  31. ncbi request reprint Delayed harvesting of sentinel lymph nodes after previous wide local excision of extremity melanoma
    Stanley P L Leong
    Department of Surgery, Melanoma Center, University of California, San Francisco Medical Center at Mount Zion, San Francisco, California, USA
    Ann Surg Oncol 10:196-200. 2003
    ..The aim of our study was to determine whether delayed SSL is useful in detecting micrometastasis to the regional basin in patients with previous WLE of an extremity melanoma...
  32. ncbi request reprint Selective sentinel lymph node mapping and dissection for malignant melanoma
    Stanley P L Leong
    Sentinel Lymph Node Program, Department of Surgery, University of California, San Francisco Medical Center at Mount Zion, UCSF Comprehensive Cancer Center, San Francisco, California, USA
    Cancer Treat Res 111:39-64. 2002
  33. ncbi request reprint Routine imaging of asymptomatic melanoma patients with metastasis to sentinel lymph nodes rarely identifies systemic disease
    Edward P Miranda
    Department of Surgery, University of California San Francisco, 94143 1974, USA
    Arch Surg 139:831-6; discussion 836-7. 2004
    ....
  34. ncbi request reprint Paradigm of metastasis for melanoma and breast cancer based on the sentinel lymph node experience
    Stanley P L Leong
    Department of Surgery, University of California, San Francisco, UCSF Comprehensive Cancer Center, and UCSF Medical Center at Mount Zion, San Francisco, California, USA
    Ann Surg Oncol 11:192S-7S. 2004
    ..Better understanding of the molecular and genetic mechanisms of metastasis will be critical to select high-risk patients for adjuvant therapy...
  35. pmc The gene expression signatures of melanoma progression
    Christopher Haqq
    Auerback Melanoma Research Laboratory, Melanoma Center and Department of Dermatology, Cutaneous Oncology Program, University of California at San Francisco UCSF Comprehensive Cancer Center, San Francisco, CA 94115, USA
    Proc Natl Acad Sci U S A 102:6092-7. 2005
    ..The gene expression signatures identified here provide the basis for developing new diagnostics and targeting therapies for patients with malignant melanoma...
  36. ncbi request reprint Future perspectives and unanswered questions on cancer metastasis and the lymphovascular system
    Stanley P L Leong
    University of California San Francisco, San Francisco, California, USA
    Cancer Treat Res 135:293-6. 2007
  37. ncbi request reprint Selective sentinel lymphadenectomy for malignant melanoma
    Stanley P L Leong
    Department of Surgery, University of California at San Francisco, University of California at San Francisco Comprehensive Cancer Center at Mount Zion, 1600 Divisadero Street, San Francisco, CA 94143 1674, USA
    Surg Clin North Am 83:157-85, vii. 2003
    ..It is important for investigators involved with SSL to follow the clinical outcome of their patients so that the role of SSL can be further defined...
  38. ncbi request reprint Selective sentinel lymph node mapping and dissection for breast cancer
    Stanley P L Leong
    Sentinel Lymph Node Program, Department of Surgery, University of California, San Francisco Medical Center at Mount Zion, UCSF Comprehensive Cancer Center, San Francisco, California, USA
    Cancer Treat Res 111:65-79. 2002
  39. ncbi request reprint Selective sentinel lymphadenectomy for malignant melanoma, Merkel cell carcinoma, and squamous cell carcinoma
    Stanley P L Leong
    Department of Surgery, University of California, San Francisco Medical Center at Mount Zion, USA
    Cancer Treat Res 127:39-76. 2005
    ..It is important for investigators involved with the SSL to follow the clinical outcome of these patients, so that the role of SSL can be further defined...
  40. ncbi request reprint Coexisting tattoo pigment and metastatic melanoma in the same sentinel lymph node
    Adnan A Jaigirdar
    Departments of Surgery and Pathology, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, UCSF Medical Center at Mount Zion, San Francisco, CA 94115, USA
    J Cutan Med Surg 13:321-5. 2009
    ..We present two cases of melanoma arising within the setting of a tattoo where the sentinel lymph node contained both pigmented histiocytes and metastatic melanoma on gross inspection and histopathology...
  41. ncbi request reprint Ratio of positive to total number of sentinel nodes predicts nonsentinel node status in breast cancer patients
    Yah Yuen Tan
    Department of Surgery, UCSF Medical Center at Mount Zion and UCSF Comprehensive Cancer Center, San Francisco, California 94143 1674, USA
    Breast J 11:248-53. 2005
    ....
  42. pmc Pleckstrin homology domain-interacting protein (PHIP) as a marker and mediator of melanoma metastasis
    David De Semir
    Auerback Melanoma Research Laboratory and Melanoma Center, University of California, San Francisco, CA 94115, USA
    Proc Natl Acad Sci U S A 109:7067-72. 2012
    ..These results describe previously unreported roles for PHIP in predicting and promoting melanoma metastasis, and in the molecular classification of melanoma...
  43. ncbi request reprint Paradigm shift of staging and treatment for early breast cancer in the sentinel lymph node era
    Stanley P L Leong
    Department of Surgery, University of California and UCSF Comprehensive Cancer Center at Mount Zion, San Francisco, California 94143 1674, USA
    Breast J 12:S128-33. 2006
    ..The challenge in the future will be to dissect these different patterns of metastasis based on molecular or genetic markers. Such information will be critical to select high-risk patients for adjuvant therapy...
  44. ncbi request reprint Prognostic factors in patients with thick cutaneous melanoma (> 4 mm)
    Elizabeth Zettersten
    Melanoma Center, Cutaneous Oncology Program, University of California at San Francisco, Comprehensive Cancer Center, San Francisco, California 94115, USA
    Cancer 94:1049-56. 2002
    ..The current study was conducted to examine the role of multiple clinical and histologic factors in the prognostic assessment of patients with thick primary melanoma (> 4 mm, classified as T4)...
  45. ncbi request reprint Sentinel lymph node mapping and selective lymphadenectomy: the standard of care for melanoma
    Stanley P L Leong
    Department of Surgery, University of California, San Francisco Mount Zion Medical Center and UCSF Comprehensive Cancer Center, 1600 Divisadero Street, Room C333, San Francisco, CA 94143, USA
    Curr Treat Options Oncol 5:185-94. 2004
    ..A complete LN dissection is performed if the SLN is positive. It is important to follow the clinical outcome of patients undergoing SSL, thus its role can be further defined...
  46. doi request reprint Getting to better cancer care: results of a society of surgical oncology survey
    Sandra L Wong
    Department of Surgery, Division of Surgical Oncology, University of Michigan, 1500 E Medical Center Drive, 3310 CCC, Ann Arbor, MI, 48109 5932, USA
    Ann Surg Oncol 15:2363-71. 2008
    ..A survey of its members was conducted to determine which domains of "outcomes" are important and relevant to surgical oncologists...
  47. ncbi request reprint Failure to harvest sentinel lymph nodes identified by preoperative lymphoscintigraphy in breast cancer patients
    Chen Teng Wu
    Department of Surgery, University of California, San Francisco UCSF Medical Center at Mount Zion, 94143 1674, USA
    Breast J 9:86-90. 2003
    ..The possibility of failure to get the SLN should be explained to patients before surgery. Axillary lymph node dissection (ALND) should be done if selective SLN dissection is not successful...
  48. doi request reprint Is head and neck melanoma different from trunk and extremity melanomas with respect to sentinel lymph node status and clinical outcome?
    Niloofar Fadaki
    Center for Melanoma Research and Treatment, California Pacific Medical Center, San Francisco, CA, USA
    Ann Surg Oncol 20:3089-97. 2013
    ..This study was conducted to evaluate and compare the effect of the anatomic locations of primary melanoma on long-term clinical outcomes...
  49. ncbi request reprint Patellar metastatic melanoma in a 13-year-old boy
    Thomas F Burk
    Department of Orthopaedic Surgery, University of California, San Francisco, USA
    Am J Orthop (Belle Mead NJ) 39:582-6. 2010
    ....
  50. ncbi request reprint Cancer research and clinical trial in action: an important exercise before you embark on your study
    Larry Carbone
    Department of Vetinary Medicine, UCSF Medical Center, San Francisco, CA, USA
    Cancer Treat Res 132:291-309. 2007
  51. ncbi request reprint Future perspectives for cancer metastasis and the lymphovascular system
    Stanley P L Leong
    Department of Surgery, University of California, and UCSF Comprehensive Cancer Center, San Francisco, CA 94143 1674, USA
    Cancer Metastasis Rev 25:293-4. 2006
  52. ncbi request reprint Future perspectives on malignant melanoma
    Stanley P L Leong
    Department of Surgery, University of California at San Francisco Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, CA 94143 1674, USA
    Surg Clin North Am 83:453-6, x. 2003
    ..If such mechanisms can be understood, potential therapeutic maneuvers can be developed to prevent the process of micrometastasis...
  53. ncbi request reprint Cytokine profiles of sentinel lymph nodes draining the primary melanoma
    Stanley P L Leong
    Department of Surgery, University of California at San Francisco Comprehensive Cancer Center Mount Zion, 94143 1674, USA
    Ann Surg Oncol 9:82-7. 2002
    ..The sentinel lymph node (SLN) draining the primary melanoma is the first echelon node where micrometastasis is established. SLNs may be the initial sites of antigen presentation associated with immune responses...
  54. ncbi request reprint Image of the month: angiosarcoma of the breast
    Justin Parekh
    Department of Surgery, University of California San Francisco, 1600 Divisadero Street, San Francisco, CA 94143, USA
    Arch Surg 140:809-10. 2005
  55. ncbi request reprint The role of the principal investigator in cancer clinical trials
    Stanley P L Leong
    Department of Surgery, UCSF Comprehensive Cancer Center, San Francisco, California, USA
    Cancer Treat Res 132:157-77. 2007
    ..Every PI should be well prepared to meet the complex challenges inherent in conducting clinical trials and be proud to be engaged in the search for a "cure" for cancer patients...